REFERENCES

1. Goletti D, Meintjes G, Andrade BB, Zumla A, Shan Lee S. Insights from the 2024 WHO global tuberculosis report - more comprehensive action, innovation, and investments required for achieving WHO end TB goals. Int J Infect Dis. 2025;150:107325.

2. Xue D, Chen X, Shao L, et al. Risk factors for the progression from pulmonary tuberculosis to spinal tuberculosis: a logistic regression analysis. J Orthop Surg. 2025;20:422.

3. Sendrea B, Periferakis A, Periferakis A, et al. Infectious spondylodiscitis of bacterial causes in adults: epidemiology, pathophysiology, diagnostic and treatment challenges. Microorganisms. 2026;14:1110.

4. Huang L, Nazarova EV, Russell DG. Mycobacterium tuberculosis: bacterial fitness within the host macrophage. Microbiol Spectr. 2019;7:7.2.04.

5. Shi L, Jiang Q, Bushkin Y, Subbian S, Tyagi S. Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis infection. mBio. 2019;10:e02550-18.

6. Prosser G, Brandenburg J, Reiling N, Barry CE, Wilkinson RJ, Wilkinson KA. The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition. Microbes Infect. 2017;19:177-92.

7. Ravesloot-Chávez MM, Van Dis E, Stanley SA. The innate immune response to Mycobacterium tuberculosis infection. Annu Rev Immunol. 2021;39:611-37.

8. He Y, Xie X, He S, Li S, Zhou H, Wei S. Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives. Front. Immunol. 2026;17:1859046.

9. Lou C, Liu J, Ren Z, et al. Analysis of the value of serum biomarker LBP in the diagnosis of spinal tuberculosis. Infect Drug Resist. 2022;15:4915-26.

10. Luo R, Yao Y, Chen Z, Sun X. An examination of the LPS-TLR4 immune response through the analysis of molecular structures and protein-protein interactions. Cell Commun Signal. 2025;23:142.

11. Mukherjee S, Huda S, Sinha Babu SP. Toll‐like receptor polymorphism in host immune response to infectious diseases: a review. Scand J Immunol. 2019;90:e12771.

12. Elhadedy N, Alotaibi A, Mcgarry L, Carmody RJ. Toll-like receptor responses are shaped by distinct MAPK activation profiles. The Journal of Immunology. 2026;215:vkag180.

13. Xie H, Liu H, Xiu Y, et al. Activation of GABABR alleviates colitis by reprogramming macrophage polarization via the IRAK-M/NLRP3/NF-κB pathway. Biochem Pharmacol. 2026;252:118227.

14. Tsukamoto H, Takeuchi S, Kubota K, et al. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation. J Biol Chem. 2018;293:10186-201.

15. Sheidae Mehne Z, Honarjou E, Khamoushi Kahdouee M. Chronic infections of the spine: a systematic review of microbial etiologies, diagnostic approaches, and treatment outcomes. Int J Infect Dis. 2026;169:108769.

16. Su GL, Simmons RL, Wang SC. Lipopolysaccharide binding protein participation in cellular activation by LPS. Crit Rev Immunol. 1995;15:201-14.

17. Juffermans NP, Verbon A, Van Deventer SJH, et al. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J INFECT DIS. 1998;178:1839-42.

18. Schumann RR. Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans. 2011;39:989-93.

19. Futami Y, Takeda Y, Koba T, et al. Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles. Int Immunol. 2022;34:327-40.

20. Shi Z, Wang Y, Gu Y, Zhu M, Li M, Yu Q. Indolicidin attenuates inflammation by modulating the TLR4 signaling pathway during sepsis progression. ACS Infect. Dis. 2026;12:2288-302.

21. Ma Y, Jiang Q. NF-κB signaling in acute myocardial infarction: pathophysiology, inflammation, and therapeutic implications. Front. Cardiovasc. Med. 2026;13:1847945.

22. Zhang Q, Sun J, Fu Y, et al. Guttiferone K Exerts the anti-inflammatory effect on Mycobacterium tuberculosis- (H37Ra-) infected macrophages by targeting the TLR/IRAK-1 mediated Akt and NF-κB pathway. Mediators Inflamm. 2020;2020:1-16.

23. Benedetto GL, Parrotta EI, Covello R, et al. Synovial fluid proteomic biomarkers in periprosthetic joint infection: a systematic review with gene ontology and protein network analyses. J. exp. orthop. 2026;13:e70853.

24. Arya R, Shakya H, Chaurasia R, Haque MA, Kim J. Exploring the role of extracellular vesicles in the pathogenesis of tuberculosis. Genes. 2024;15:434.

25. Jain M, Anuja AK, Yadav S, Ara J, Ojha A, Chaturvedi CP. Non-coding RNA in osteoarthritis: mechanistic insights and future perspectives. Front. Endocrinol. 2026;17:1851589.

26. Anderson NL, Anderson NG. The human plasma proteome. Mol Cell Proteomics. 2002;1:845-67.

27. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-54.

Science Orthopedics
ISSN : XXXX-XXXX (Coming soon)
Navigation
Navigation